Home » Trials » Trial #279 » original TRDS


Original TRDS for trail "The impact of clinical pharmacy services for diabetic outpatients in Sri Lanka" created on Apr 23, 2017


SLCTR Registration Number

SLCTR/2014/034


Date of Registration

05 Dec 2014

The date of last modification

Apr 23, 2017


View original TRDS



Application Summary


Scientific Title of Trial

A pharmacist-led program to improve patient management of medications in diabetes in rural and urban outpatient settings in Sri Lanka


Public Title of Trial

The impact of clinical pharmacy services for diabetic outpatients in Sri Lanka


Disease or Health Condition(s) Studied

Diabetes


Scientific Acronym

None


Public Acronym

None


Brief title

None


Universal Trial Number

None


Any other number(s) assigned to the trial and issuing authority

None


Trial Details


What is the research question being addressed?

Do clinically oriented services of pharmacists improve the drug management by diabetic patients attending hospital outpatient clinics?


Type of study

Interventional


Study design

Allocation

Non-randomized controlled trial


Masking

Single blinded


Control

Standard therapy


Assignment

Parallel


Purpose

Health services research


Study Phase


Intervention(s) planned

Participants will be recruited from the Colombo North Teaching hospital and Dambadeniya Base hospital, Sri Lanka.

Those in the intervention arm will receive verbal counseling on the prescribed drugs (drug name, indication, dose, side effects) as repetitive episodes for 4 consecutive clinic visits

After the physician visit, the patients will be provided with verbal counseling regarding their medicines by a graduate pharmacist. The patient will be sent to the dispensing pharmacist with printed packets including details regarding the drug.

The control group will receive standard clinic care.


Inclusion criteria

Patients who have type 1 and type 2 diabetes at least for three years with or without complications


Exclusion criteria

Patients who cannot speak and understand Sinhala or English and patients who do not consent



Primary outcome(s)

1.

Disease control as defined by changes in 1. HbA1c 2.Fasting blood glucose

[

At four months following recruitment

]

Secondary outcome(s)

1.

Knowledge about drugs and adherence to those using a validated questionnaire

[

At baseline and at the last day of follow up at the clinic.

]

Target number/sample size

800


Countries of recruitment

Sri Lanka


Anticipated start date

2014-12-05


Anticipated end date

2015-10-05


Date of first enrollment


Date of study completion


Recruitment status

Complete


Funding source

National Research Council


Regulatory approvals



State of Ethics Review Approval


Status


Date of Approval


Approval number


Details of Ethics Review Committee

Name:
Institutional Address:
Telephone:
Email:

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

S. F. Jayamanne
Senior Lecturer
Department of Medicine, Faculty of Medicine, Ragama
0112953451
0773014722

shalukajaya@yahoo.com

Contact Person for Public Queries

S. F. Jayamanne
Senior Lecturer
Department of Medicine, Faculty of Medicine, Ragama
0112953451
0773014722

shalukajaya@yahoo.com


Primary study sponsor/organization

National Research Council

380/97, Bauddhaloka Mawatha, Colombo 07
011-2695060
011-2675136
nrc@sltnet.lk
nrc.gov.lk

Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?


IPD sharing plan description


Study protocol available


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results